Novartis is going after a $5 billion market with a new treatment for vision loss. That's a big threat to Regeneron

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

Novartis' drug brolucizumab just showed that it wasn't any worse than Eylea, a drug from Regeneron, at treating an eye disease.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in NG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

J&J announces $5 billion share buyback program after report wipes out $50 billion in market valueJohnson & Johnson plans to repurchase $5 billion in shares after the company lost more than $50 billion in market value over two trading days following a scathing news report Friday claiming J&J knew its talc baby powders contained asbestos. Using the money from remorseless trump and remorseless Republicans they gave corporations in 2016 tax scam ! Asbestos isn't safe though. 1/7 men experience prostate in their lifetimes. This product has been around like 47 years. The uptick of prostate cancer correlates. They've lied about asbestos in the talcum. We will never know the disastrous effects this has caused the world. Scrambling to boost the share price of their executive stock options. What a wise use of R&D capital.
Source: CNBC - 🏆 12. / 72 Read more »

Art market faces big test as $2 billion worth of artwork goes up for auctionIt is the biggest auction week of the year, and the biggest test for the art market. Check out the paintings expected to sell for tens of millions of dollars apiece, some of which could set records. 🤮🤮🤮
Source: CNBC - 🏆 12. / 72 Read more »